Market Tracker

09/23 5:16pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

410.39
Delayed Data
As of Sep 23
 +2.38 / +0.58%
Today’s Change
329.09
Today|||52-Week Range
592.59
-24.40%
Year-to-Date

Today’s Trading

Previous close408.01
Today’s open405.57
Day’s range405.57 - 413.62
Volume689,342
Average volume (3 months)830,527
Market cap$43.2B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-9.37%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+45.55%
P/E ratio64.0
Price/Sales15.24
Price/Book11.75

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-6.47-4.84%
BAXBaxter International...-0.71-1.47%
ZTSZoetis Inc-0.12-0.23%
SHPGShire-1.17-0.57%
Data as of 4:00pm ET, 09/23/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$2.72
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts